| |
|
|
|
Antares Pharma  
|
|
3.125 0.005 (0%) |
11-30 15:36 |
|
Open: |
3.13 |
Pre close: |
3.12 |
Target:
|
3.76 
|
|
High: |
3.22 |
Low: |
3.09 |
Resistance:
|
3.22
3.76
|
|
Volume: |
866,959 |
Market Cap: |
521M |
Support:
|
2.90
2.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.05
|
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
2.95 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
2.88 |
Stochastic Oscillator |
%K(14,3):
|
82.63  |
|
MA(250): |
3.12 |
%D(3): |
76.63 |
|
Average Volume(K) |
3-Month: |
86504
|
52-Week |
High:
|
5.11 |
|
10-Days: |
78926 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
59.25 |
Change(%): |
-38.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.057 |
Return on Equity (ttm) |
17.3 |
Shares Out. (M) |
166.67 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
5.9 |
Shares Float (M) |
153.97 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.48 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
16.6 |
% Held by Institutions |
42.90 |
|
Forward EPS |
-0.010 |
Gross Profit (p.s.) |
0.440 |
Shares Short (K) |
4050 |
|
Book Value (p.s.) |
0.390 |
EBITDA (p.s.) |
0.093 |
P/E |
55.00 |
|
Sales Per Share |
0.860 |
Qtrly Earnings Growth |
379.00 |
P/BV |
8.04 |
|
Profit Margin |
6.64 |
Operating Cash Flow
(M) |
13.09 |
P/S |
3.65 |
|
Operating Margin |
9.13 |
Levered Free Cash Flow
(M) |
3.09 |
P/CF |
39.92 |
|
|
|
|
|
|
